CD44 and neoplasm: In contrast, based on the expression of CD44 and IFN-γ, no difference was observed in the activation of dLN CD8+ T cells from Shp2f/fLckCre mice compared to Shp2f/f tumor-bearing mice (Fig. 1b–d).